[go: up one dir, main page]

AU6542898A - Sialyl lewis antigens as targets for immunotherapy - Google Patents

Sialyl lewis antigens as targets for immunotherapy

Info

Publication number
AU6542898A
AU6542898A AU65428/98A AU6542898A AU6542898A AU 6542898 A AU6542898 A AU 6542898A AU 65428/98 A AU65428/98 A AU 65428/98A AU 6542898 A AU6542898 A AU 6542898A AU 6542898 A AU6542898 A AU 6542898A
Authority
AU
Australia
Prior art keywords
immunotherapy
targets
sialyl lewis
lewis antigens
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65428/98A
Other languages
English (en)
Inventor
Donald L. Morton
Mepur H Ravindranath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wayne Cancer Institute
Original Assignee
John Wayne Cancer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wayne Cancer Institute filed Critical John Wayne Cancer Institute
Publication of AU6542898A publication Critical patent/AU6542898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053Skin, nerves, brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001169Tumor associated carbohydrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU65428/98A 1997-03-05 1998-03-05 Sialyl lewis antigens as targets for immunotherapy Abandoned AU6542898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81128197A 1997-03-05 1997-03-05
US08811281 1997-03-05
PCT/US1998/004314 WO1998039027A2 (fr) 1997-03-05 1998-03-05 Antigenes de sialyl lewis uilises comme cibles en immunotherapie

Publications (1)

Publication Number Publication Date
AU6542898A true AU6542898A (en) 1998-09-22

Family

ID=25206107

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65428/98A Abandoned AU6542898A (en) 1997-03-05 1998-03-05 Sialyl lewis antigens as targets for immunotherapy

Country Status (2)

Country Link
AU (1) AU6542898A (fr)
WO (1) WO1998039027A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349567A4 (fr) * 2000-12-08 2005-10-12 Childrens Memorial Hospital Compositions contenant des gangliosides pour le traitement de pathologies de la peau
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
EP1417965A1 (fr) * 2002-11-07 2004-05-12 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Molécules capables de se lier à des lectines de type-C, leur identification et usages
AU2006210660B2 (en) 2005-02-01 2011-12-01 Morphosys Ag Libraries and methods for isolating antibodies
FR2919804B1 (fr) * 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US10384796B2 (en) * 2012-04-04 2019-08-20 Commercial Aerospace Plane Pty Limited Aerospace plane system
KR20160054501A (ko) * 2013-08-26 2016-05-16 맵백스 테라퓨틱스, 인코포레이티드 시알릴-루이스 a에 대한 사람 항체 코드화 핵산
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
US12201652B2 (en) 2016-05-03 2025-01-21 Stemcell Technologies Canada Inc. Intracellular delivery of biomolecules to induce tolerance
WO2018102682A1 (fr) 2016-12-01 2018-06-07 Regeneron Pharmaceuticals, Inc. Anticorps anti-pd-l1 radiomarqués pour imagerie immuno-pet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04304897A (ja) * 1991-04-01 1992-10-28 Kyowa Hakko Kogyo Co Ltd 抗イディオタイプモノクローナル抗体
WO1992022565A1 (fr) * 1991-06-10 1992-12-23 Alberta Research Council Composes modifies de lewisx au sialyl
US6841543B1 (en) * 1996-01-31 2005-01-11 President And Fellows Of Harvard College Methods of inhibiting production of T helper type 2 cytokines in human immune cells

Also Published As

Publication number Publication date
WO1998039027A3 (fr) 1999-01-07
WO1998039027A2 (fr) 1998-09-11

Similar Documents

Publication Publication Date Title
ZA964614B (en) Methods for the preparation of substantially monomeric callcheamicin derivative carrier conjugates.
AU1360799A (en) Curved introduction for mass spectrometry
AU1290001A (en) Antibodies
AU2341300A (en) Improved projectile tracking system
AU2958997A (en) Concentrated antibody preparation
AU6677498A (en) Process for preparing refrigerated meals
AU6683098A (en) Liner holder assembly
AU4935000A (en) Antibodies
AU699267B2 (en) Dual size cup carrier
AU3241897A (en) Synchronizer
AU6542898A (en) Sialyl lewis antigens as targets for immunotherapy
AUPN178995A0 (en) Antigen composition
AU5775698A (en) Mammalian equilibrative nucleoside transporters
AUPN871296A0 (en) Multicoat for light transmitting articles
AUPO712097A0 (en) Vacuum deposition system
AU7572198A (en) Tumor-associated antigen
EP0867579A3 (fr) Bandeau décoratif de rive et de sous-rive
AU3225097A (en) Immunotherapy for autoimmune disease
AU7295198A (en) System for the distribution of narcotics
AU6272098A (en) Dendritic cell-derived growth factor
AU1971699A (en) Method for preparing silicon with high purity ester function
AU4850196A (en) Installation for preparing hot drinks
AU3480999A (en) Targeting of specific cell types for removal by the immune system
AU5929898A (en) Built-in vacuum system
AU7788600A (en) Colon-tumour-associated antigens